LDL Mid B is an intermediate-small LDL particle subfraction, sitting between the mid-large and the small dense LDL particles. As particles become smaller and denser along the LDL spectrum, they become progressively more atherogenic — more capable of penetrating the arterial wall and contributing to plaque.
Elevated LDL Mid B alongside elevated small dense LDL particles indicates a shift in the LDL particle profile toward greater atherogenicity, even when total LDL appears normal or mildly elevated. This pattern is often seen in metabolic syndrome, type 2 diabetes, and insulin resistance, where the liver produces smaller, denser LDL particles.
FAQs
Why is LDL Mid B more dangerous than LDL Mid A?
LDL particles become progressively more atherogenic as they become smaller and denser. LDL Mid B is smaller than LDL Mid A, making it more likely to penetrate arterial walls and undergo oxidation, contributing more to plaque formation.
Is LDL Mid B related to triglycerides?
Yes. High triglycerides drive the production of smaller, denser LDL particles including LDL Mid B through CETP-mediated lipid exchange. Lowering triglycerides through carbohydrate restriction reduces production of these atherogenic particles.
How is this different from testing total LDL?
Total LDL cholesterol doesn't distinguish between particle sizes. Two people with identical LDL cholesterol can have very different cardiovascular risk depending on whether their LDL is predominantly large (less risky) or small and dense (more risky).
Who benefits most from subfraction testing?
People with metabolic syndrome, diabetes, borderline LDL, or cardiovascular disease despite apparently normal LDL benefit most from understanding their particle size distribution.
